Balance Sheet
Accounts PayablesAccumulated DepreciationAccumulated ExpensesAssetsCash & EquivalentsCommon EquityCurrent AssetsCurrent Deferred RevenueLiabilities and Shareholders EquityLong-Term InvestmentsNon-Current AssetsNon-Current Deffered RevenueOther Accumulated ExpensesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)ReceivablesReceivables - NetRetained EarningsShareholder's EquityTotal Current LiabilitiesTotal LiabilitiesTotal Non-Current LiabilitiesTreasury Shares
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Aclaris Therapeutics (ACRS) Inventory: 2018-2019

Historic Inventory for Aclaris Therapeutics (ACRS) over the last 2 years, with Sep 2019 value amounting to $189,000.

  • Aclaris Therapeutics' Inventory fell 81.90% to $189,000 in Q3 2019 from the same period last year, while for Sep 2019 it was $189,000, marking a year-over-year decrease of 81.90%. This contributed to the annual value of $791,000 for FY2018, which is N/A change from last year.
  • Aclaris Therapeutics' Inventory amounted to $189,000 in Q3 2019, which was up 2.16% from $185,000 recorded in Q2 2019.
  • Aclaris Therapeutics' 5-year Inventory high stood at $1.0 million for Q3 2018, and its period low was $185,000 during Q2 2019.
  • Moreover, its 2-year median value for Inventory was $823,500 (2018), whereas its average is $681,833.
  • Data for Aclaris Therapeutics' Inventory shows a maximum YoY plummeted of 81.97% (in 2019) over the last 5 years.
  • Aclaris Therapeutics' Inventory (Quarterly) stood at $791,000 in 2018, then plummeted by 81.90% to $189,000 in 2019.
  • Its last three reported values are $189,000 in Q3 2019, $185,000 for Q2 2019, and $856,000 during Q1 2019.